Valuation: Nexentis Technologies Inc.

Market Cap 817K 734K 677K 614K 1.15M 77.72M 1.16M 8.13M 3.23M 40.72M 3.07M 3M 129M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -2.26M -2.03M -1.87M -1.7M -3.18M -215M -3.22M -22.5M -8.94M -113M -8.49M -8.31M -357M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
87.05%
Yield 2024 *
-
Yield 2025 -
1 day+3.15%
1 week-9.43%
Current month-58.27%
1 month-60.54%
3 months-67.78%
6 months-88.40%
Current year-95.07%
1 week 0.5
Extreme 0.5046
0.61
1 month 0.5
Extreme 0.5046
1.5
Current year 0.5
Extreme 0.5046
23.8
1 year 0.5
Extreme 0.5046
25.83
3 years 0.5
Extreme 0.5046
1,849.73
5 years 0.5
Extreme 0.5046
15,006.28
10 years 0.5
Extreme 0.5046
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 2020-11-04
Director of Finance/CFO 39 2022-04-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 54 2020-08-25
Chairman 62 2021-05-23
Director/Board Member 54 2020-08-25
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Free

Chief Financial Officer

50,000 1.8639%
2/9/26 Free

Chairman

116,286 4.3350%
2/9/26 Free

Chief Executive Officer

100,000 3.7279%
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%-9.43%-97.78%-99.90% 817K
+1.67%-0.67%+19.70%+25.48% 32.63B
-0.25%+1.71%+39.40%+50.17% 18.29B
-0.13%-3.43%-4.35%+36.93% 17.64B
+4.68%+3.01%-5.44%-10.05% 14.1B
+0.11%-.--%-.--%-.--% 12.96B
-1.97%-2.45%+4.46%+11.58% 11.1B
+0.79%-5.53%+3.43%+162.36% 9.8B
-2.68%-8.06% - - 7.97B
-0.22%-.--%-.--%-.--% 8.3B
Average +0.52%-2.17%-4.51%+19.62% 13.28B
Weighted average by Cap. +0.59%-0.93%+10.36%+31.87%

Financials

2024 2025
Net sales 210K 189K 174K 158K 295K 19.97M 299K 2.09M 830K 10.46M 788K 771K 33.17M -
Net income -5.19M -4.67M -4.3M -3.9M -7.3M -494M -7.39M -51.66M -20.52M -259M -19.49M -19.07M -820M -4M -3.6M -3.32M -3.01M -5.63M -381M -5.7M -39.83M -15.82M -199M -15.03M -14.71M -633M
Net Debt -2.48M -2.23M -2.06M -1.87M -3.49M -236M -3.54M -24.72M -9.82M -124M -9.33M -9.13M -393M -3.08M -2.77M -2.55M -2.31M -4.33M -293M -4.38M -30.63M -12.17M -153M -11.56M -11.31M -486M
Projected Income Statement - Annual - Nexentis Technologies Inc.
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
26-10-27 US$0.5800 +3.15% 145,186
26-10-26 US$0.5623 +7.27% 543,960
26-10-23 US$0.5242 -7.55% 30,816
26-10-22 US$0.5670 +4.67% 32,347
26-10-21 US$0.5417 -11.96% 151,864
  1. Stock Market
  2. Stocks
  3. NXTS Stock